HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.

AbstractCONTEXT:
Abnormally high expression of N6-methyladenosine (m6A) methyltransferase-like 3 (METTL3) has been implied to accompany thyroid carcinoma (TC) development.
OBJECTIVE:
This study aimed to explore the protumorigenic role and downstream signaling axis of METTL3 in TC.
METHODS:
This study was conducted at the Sun Yat-Sen Memorial Hospital Sun Yat-Sen University. METTL3 and miR-222-3p were overexpressed or downregulated in TC cells. Tumor and adjacent normal tissues were collected from 80 patients (19 men and 60 women, aged 30-70 years) with a pathological diagnosis of TC from January 2012 to January 2015. Cells were classified and subjected to different treatments. The expression of METTL3 was validated in TC tissues and cell lines. In functional studies, METTL3 and miR-222-3p were overexpressed or downregulated in TC cells to evaluate their effects on malignant behaviors, which were subsequently verified by xenografts in nude mice.
RESULTS:
The expression of METTL3 was elevated in TC, correlating with poor prognosis of TC patients. Heightened METTL3 expression accelerated malignant behaviors of TC cells. Mechanistically, METTL3 stimulated miR-222-3p expression by mediating the m6A modification of pri-miR-222-3p. miR-222-3p targeted and inversely regulated serine/threonine stress kinase 4 (STK4). Knockdown of METTL3 augmented STK4 expression by downregulating miR-222-3p, thereby suppressing the malignant behaviors of TC cells as well as tumor growth and lung metastasis in nude mice.
CONCLUSION:
Silencing METTL3 suppresses miR-222-3p expression and thus stimulates STK4 expression, thereby repressing the malignancy and metastasis of TC.
AuthorsShaojian Lin, Yue Zhu, Chengcheng Ji, Weiming Yu, Cheng Zhang, Langping Tan, Miaoyun Long, Dingyuan Luo, Xinzhi Peng
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 107 Issue 2 Pg. 474-490 (01 18 2022) ISSN: 1945-7197 [Electronic] United States
PMID34562008 (Publication Type: Journal Article)
Copyright© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: [email protected].
Chemical References
  • Intracellular Signaling Peptides and Proteins
  • MIRN222 microRNA, mouse
  • MicroRNAs
  • N-methyladenosine
  • Methyltransferases
  • METTL3 protein, human
  • STK4 protein, human
  • Protein Serine-Threonine Kinases
  • Adenosine
Topics
  • Adenosine (analogs & derivatives, metabolism)
  • Adult
  • Aged
  • Animals
  • Cell Transformation, Neoplastic (genetics)
  • Down-Regulation
  • Female
  • Follow-Up Studies
  • Gene Knockdown Techniques
  • Humans
  • Intracellular Signaling Peptides and Proteins (genetics)
  • Kaplan-Meier Estimate
  • Male
  • Methyltransferases (genetics, metabolism)
  • Mice
  • MicroRNAs (genetics, metabolism)
  • Middle Aged
  • Protein Serine-Threonine Kinases (genetics)
  • Thyroid Gland (pathology, surgery)
  • Thyroid Neoplasms (genetics, mortality, pathology, surgery)
  • Thyroidectomy
  • Up-Regulation
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: